DE69433724D1 - Mit rekombinantem insulin-ähnlichen wachstumsfaktor igf-i vergleichbare rückfaltung von polypeptiden - Google Patents

Mit rekombinantem insulin-ähnlichen wachstumsfaktor igf-i vergleichbare rückfaltung von polypeptiden

Info

Publication number
DE69433724D1
DE69433724D1 DE69433724T DE69433724T DE69433724D1 DE 69433724 D1 DE69433724 D1 DE 69433724D1 DE 69433724 T DE69433724 T DE 69433724T DE 69433724 T DE69433724 T DE 69433724T DE 69433724 D1 DE69433724 D1 DE 69433724D1
Authority
DE
Germany
Prior art keywords
refolding
comparative
growth factor
recombinant insulin
factor igf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69433724T
Other languages
English (en)
Other versions
DE69433724T2 (de
Inventor
Stuart Builder
Roger Hart
Phillip Lester
David Reifsnyder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DE69433724D1 publication Critical patent/DE69433724D1/de
Publication of DE69433724T2 publication Critical patent/DE69433724T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69433724T 1993-08-20 1994-08-15 Mit rekombinantem Insulin-ahnlichen Wachstumsfaktor IGF-I vergleichbare Rückhaltung von Polypeptiden Expired - Lifetime DE69433724T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/110,664 US5663304A (en) 1993-08-20 1993-08-20 Refolding of misfolded insulin-like growth factor-I
US110664 1993-08-20
PCT/US1994/009120 WO1995006064A1 (en) 1993-08-20 1994-08-15 Refolding of polypeptides like recombinant insulin-like growth factor igf-i

Publications (2)

Publication Number Publication Date
DE69433724D1 true DE69433724D1 (de) 2004-05-27
DE69433724T2 DE69433724T2 (de) 2005-04-28

Family

ID=22334224

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69434919T Expired - Lifetime DE69434919T2 (de) 1993-08-20 1994-08-15 Faltung von Polypeptiden
DE69433724T Expired - Lifetime DE69433724T2 (de) 1993-08-20 1994-08-15 Mit rekombinantem Insulin-ahnlichen Wachstumsfaktor IGF-I vergleichbare Rückhaltung von Polypeptiden

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69434919T Expired - Lifetime DE69434919T2 (de) 1993-08-20 1994-08-15 Faltung von Polypeptiden

Country Status (10)

Country Link
US (3) US5663304A (de)
EP (2) EP0714406B1 (de)
JP (1) JP3648242B2 (de)
AT (2) ATE352568T1 (de)
CA (1) CA2168552C (de)
DE (2) DE69434919T2 (de)
DK (2) DK1486511T3 (de)
ES (2) ES2280857T3 (de)
PT (2) PT1486511E (de)
WO (1) WO1995006064A1 (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3545795A (en) * 1994-09-08 1996-03-27 Chiron Corporation A method of improved production of insulin-like growth factor
US6756484B1 (en) 1995-04-14 2004-06-29 Cephalon, Inc. IGF-I purification process
US5650496A (en) * 1995-04-14 1997-07-22 Cephalon, Inc. IGF-I purification process
US7193042B1 (en) 1995-06-07 2007-03-20 Chiron Corporation Methods for purifying authentic IGF from yeast hosts
US7071313B1 (en) * 1995-06-07 2006-07-04 Cephalon, Inc. Methods of purifying authentic IGF from yeast hosts
ATE253079T1 (de) * 1995-06-07 2003-11-15 Chiron Corp Methoden zur aufreinigung von authentischem igf aus hefewirtszellen
SE9504019D0 (sv) * 1995-11-13 1995-11-13 Pharmacia Ab Method for production of proteins
US20020052026A1 (en) * 1997-10-08 2002-05-02 Steven M. Vicik Methods of refolding proteins
US6265542B1 (en) 1997-10-24 2001-07-24 Genentech, Inc. Purification of molecules
US6417330B1 (en) 1998-06-01 2002-07-09 Celtrix Pharmaceuticals, Inc. Insulin-like growth factor binding protein variants
SE9802454D0 (sv) * 1998-07-08 1998-07-08 Pharmacia & Upjohn Ab Production of peptides
DK1115863T3 (da) 1998-09-22 2008-03-31 Genentech Inc Ucp4
US7399751B2 (en) * 1999-11-04 2008-07-15 Sertoli Technologies, Inc. Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells
US7342102B2 (en) 1998-11-30 2008-03-11 Genentech, Inc. Uncoupling protein 5 (UCP5)
EP1135496B1 (de) * 1998-11-30 2010-12-22 Genentech, Inc. Loslösendes protein 5 - ucp5
EP1142908A4 (de) * 1999-01-07 2002-05-22 Takeda Chemical Industries Ltd Methode zum herstellen von aktivierten proteinen
US7087411B2 (en) 1999-06-08 2006-08-08 Regeneron Pharmaceuticals, Inc. Fusion protein capable of binding VEGF
DE19930676B4 (de) * 1999-07-02 2006-01-19 Sanofi-Aventis Deutschland Gmbh Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln
CA2379823A1 (en) * 1999-07-16 2001-01-25 Human Genome Sciences, Inc. Real-time, in situ biomanufacturing process monitoring and control in response to ir spectroscopy
CN1454097A (zh) * 2000-09-08 2003-11-05 格莱风治疗公司 聚合物修饰的合成的蛋白质类
US7118737B2 (en) 2000-09-08 2006-10-10 Amylin Pharmaceuticals, Inc. Polymer-modified synthetic proteins
EP1337549B1 (de) * 2000-11-27 2006-04-05 Rmf Dictagene S.A. Verfahren zur rückfaltung von chemisch hergestellten polypeptiden
US20060252917A1 (en) * 2001-02-08 2006-11-09 University Of Utah Methods for refolding conformationally constrained peptides
KR20040062535A (ko) * 2001-09-07 2004-07-07 글로벌 바이오텍 인코포레이티드 인간 조직 유로키나아제형 플라스미노겐 활성화제 배합물
EP1314739A1 (de) * 2001-11-22 2003-05-28 Bayer Ag Verfahren zur Renaturierung rekombinanter, Disulfid-enthaltender Proteine bei hohen Proteinkonzentrationen in Gegenwart von Aminen
US7303871B2 (en) 2002-02-14 2007-12-04 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for Celiac Sprue
US8143210B2 (en) 2002-02-14 2012-03-27 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for celiac sprue
US20030224476A1 (en) * 2002-03-01 2003-12-04 Szu-Yi Chou Method of producing transglutaminase reactive compound
US7189811B2 (en) * 2002-09-06 2007-03-13 National Institute Of Immunology Process for solubilization of recombinant proteins expressed as inclusion body
ES2383595T3 (es) 2002-11-20 2012-06-22 The Board Of Trustees Of The Leland Stanford Junior University Procedimiento de diagnóstico de la celiaquía
US20050272117A1 (en) * 2003-06-23 2005-12-08 Astrazeneca Ab Method
WO2005018540A2 (en) * 2003-07-03 2005-03-03 Jannette Dufour Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants
US7579313B2 (en) 2003-11-18 2009-08-25 The Board Of Trustees Of The Leland Stanford Junior University Transglutaminase inhibitors and methods of use thereof
AU2006324163B2 (en) * 2005-12-08 2013-05-02 Amgen Inc. Improved production of glycoproteins using manganese
US20080032343A1 (en) 2005-12-22 2008-02-07 Genentech, Inc. Recombinant Production of Heparin Binding Proteins
US20090081145A1 (en) * 2005-12-23 2009-03-26 Aplagen Gmbh Process for forming disulphide bridges
RU2439076C2 (ru) * 2006-07-14 2012-01-10 Дженентек, Инк. Способ выделения повторно свернутого рекомбинантного белка из культуры прокариотических клеток (варианты)
EP2125863A1 (de) * 2006-12-23 2009-12-02 AplaGen GmbH Verfahren zur ausbildung von disulfidbrücken
US8148105B2 (en) * 2007-03-16 2012-04-03 The Board Of Trustees Of The Leland Stanford Junior University Scaleable manufacturing process for cysteine endoprotease B, isoform 2
CA2680590C (en) * 2007-03-16 2017-10-17 Jonathan David Gass Combination enzyme therapy for digestion of dietary gluten
LT3597659T (lt) 2007-07-09 2023-05-10 Genentech, Inc. Disulfidinės jungties redukcijos prevencijos būdas gaminant polipeptidą rekombinantiniu būdu
WO2010111212A1 (en) * 2009-03-26 2010-09-30 Warsaw Orthopedic, Inc. Methods of identifying potential components for targeted drug delivery compositions
SG176963A1 (en) 2009-06-22 2012-02-28 Amgen Inc Refolding proteins using a chemically controlled redox state
MX2011013417A (es) 2009-06-25 2012-03-29 Amgen Inc Procesos de purificacion por captura para proteinas expresadas en un sistema no mamifero.
US9052323B2 (en) * 2009-08-27 2015-06-09 The University Of Kansas Osmolyte mixture for protein stabilization
EP2512492A1 (de) 2009-12-14 2012-10-24 University of Massachusetts Verfahren zur hemmung von grauem star und altersweitsichtigkeit
US8906421B2 (en) * 2011-06-21 2014-12-09 Med-Genesis, Llc Methods of dissolving blood clots and the like
EA029070B1 (ru) 2013-03-14 2018-02-28 Дзе Юниверсити Оф Массачусетс Способ задержки развития катаракты и пресбиопии
US10736863B2 (en) 2015-11-13 2020-08-11 University Of Massachusetts Methods of inhibiting cataracts and presbyopia
WO2022261443A1 (en) * 2021-06-11 2022-12-15 Acutis Diagnostics, Inc. Method for enhanced direct detection of microbial antigens from biological fluids
CN117603332A (zh) * 2023-11-23 2024-02-27 基因科技（上海）股份有限公司 重组人ny-eso-1蛋白的制备方法及其应用

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518256A (en) * 1977-05-23 1985-05-21 Sanders Associates, Inc. Enhanced accuracy optical radar
US4565785A (en) * 1978-06-08 1986-01-21 The President And Fellows Of Harvard College Recombinant DNA molecule
US4673641A (en) * 1982-12-16 1987-06-16 Molecular Genetics Research And Development Limited Partnership Co-aggregate purification of proteins
US4518526A (en) * 1982-12-22 1985-05-21 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4511502A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4511503A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4512922A (en) * 1982-12-22 1985-04-23 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4620948A (en) * 1982-12-22 1986-11-04 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
IL71991A (en) * 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
SE8303626D0 (sv) * 1983-06-23 1983-06-23 Kabigen Ab A recombinant plasmid a transformant microorganism, a polydoxyrebonucleotide segment, a process for producing a biologically active protein, and the protein thus produced
WO1985000831A1 (en) * 1983-08-10 1985-02-28 Amgen Microbial expression of insulin-like growth factor
US4710473A (en) * 1983-08-10 1987-12-01 Amgen, Inc. DNA plasmids
US5028531A (en) * 1984-03-19 1991-07-02 Fujisawa Pharmaceutical Company, Ltd. IGF-I fusion proteins; protection of IGF-I from degradation by host cell; and processes for the production thereof
DK108685A (da) * 1984-03-19 1985-09-20 Fujisawa Pharmaceutical Co Vaekstfaktor i
US4738921A (en) * 1984-09-27 1988-04-19 Eli Lilly And Company Derivative of the tryptophan operon for expression of fused gene products
US4572798A (en) * 1984-12-06 1986-02-25 Cetus Corporation Method for promoting disulfide bond formation in recombinant proteins
US4795706A (en) * 1985-01-31 1989-01-03 Eli Lilly And Company Novel expression control sequences
US4652630A (en) * 1985-02-22 1987-03-24 Monsanto Company Method of somatotropin naturation
ATE63757T1 (de) * 1985-03-28 1991-06-15 Chiron Corp Expression durch verwendung von fusionsgenen fuer proteinproduktion.
GB8508340D0 (en) * 1985-03-29 1985-05-09 Creighton T E Production of protein
ES2029785T3 (es) * 1985-10-21 1992-10-01 Fujisawa Pharmaceutical Co., Ltd. Procedimiento para producir factor de crecimiento tipo insulina i y plasmido para su produccion.
JPH0759598B2 (ja) * 1986-02-14 1995-06-28 藤沢薬品工業株式会社 ヒトインスリン様成長因子▲ｉ▼の製造法
US4705848A (en) * 1986-06-02 1987-11-10 International Minerals & Chemical Corp. Isolation of bioactive, monomeric growth hormone
EP0264074B1 (de) * 1986-10-09 1992-12-30 Fujisawa Pharmaceutical Co., Ltd. Expressionsvektor für menschlichen insulinähnlichen Wachstumsfaktor-I
JP2502563B2 (ja) * 1987-02-20 1996-05-29 松下電器産業株式会社 フロントパネルの外観仕上げ方法
US5104796A (en) * 1987-04-06 1992-04-14 International Minerals & Chemical Corp. High titer production of human somatomedin c
IL86090A (en) * 1987-04-16 1993-03-15 Cetus Oncology Corp Production of purified, biologically active, bacterially produced recombinant human csf-1
ES2007309T3 (es) * 1987-04-23 1994-11-01 Monsanto Co Secrecion del factor de crecimiento insulinoide 1 en e.coli.
DE3855986T2 (de) * 1987-05-11 1998-02-05 Chiron Corp Prozess zur gewinnung von gereinigtem, oxidiertem, renaturiertem, rekombinantem interleukin-2 aus mikroorganismen
JPS63294796A (ja) * 1987-05-27 1988-12-01 Sagami Chem Res Center タンパク質の再賦活化方法
IL86455A0 (en) * 1987-06-01 1988-11-15 Takeda Chemical Industries Ltd Polypeptide and production thereof
US4985544A (en) * 1987-08-04 1991-01-15 Kyowa Hakko Kogyo Co., Ltd. Process for renaturing fish growth hormone
JPH01132598A (ja) * 1987-10-14 1989-05-25 Pitman Moore Inc 変性剤溶液中に含まれる組換え蛋白質における分子内ジスルフィド結合の生成を促進する方法
CA1340586C (en) * 1988-09-23 1999-06-08 Cetus Corporation Process for recovering microbially produced interferon-beta
US4923967A (en) * 1988-09-26 1990-05-08 Eli Lilly And Company Purification and refolding of recombinant proteins
US5191063A (en) * 1989-05-02 1993-03-02 University Of Medicine And Dentistry Of New Jersey Production of biologically active polypeptides by treatment with an exogenous peptide sequence
GB8915130D0 (en) * 1989-06-30 1989-08-23 Univ Dundee Enzyme production
EP0647713B1 (de) * 1989-07-19 1998-05-13 Tonen Corporation Peptidyl prolyl-cis.trans-isomersae
US5124444A (en) * 1989-07-24 1992-06-23 Microprobe Corporation Lactam-containing compositions and methods useful for the extraction of nucleic acids
US5158875A (en) * 1989-08-25 1992-10-27 Amgen Inc. Production of biologically active insulin-like growth factor i from high expression host cell systems
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
ATE154073T1 (de) * 1990-08-20 1997-06-15 Novo Nordisk As Prozess für die herstellung von biologisch aktivem igf-1 durch verwendung von amino-terminal verlängertem igf-1
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
EP0586667A1 (de) * 1992-03-24 1994-03-16 Synergen, Inc. Rückfaltung und Reinigung von insulinähnlichen Wachstumsfaktor I

Also Published As

Publication number Publication date
JPH09501693A (ja) 1997-02-18
ATE264872T1 (de) 2004-05-15
ES2280857T3 (es) 2007-09-16
ES2219649T3 (es) 2004-12-01
DE69434919T2 (de) 2007-11-29
CA2168552A1 (en) 1995-03-02
US5756672A (en) 1998-05-26
PT1486511E (pt) 2007-04-30
DE69434919D1 (de) 2007-03-15
CA2168552C (en) 2000-02-15
US5808006A (en) 1998-09-15
DE69433724T2 (de) 2005-04-28
DK0714406T3 (da) 2004-07-26
EP1486511A1 (de) 2004-12-15
EP0714406A1 (de) 1996-06-05
US5663304A (en) 1997-09-02
PT714406E (pt) 2004-09-30
ATE352568T1 (de) 2007-02-15
EP1486511B1 (de) 2007-01-24
JP3648242B2 (ja) 2005-05-18
WO1995006064A1 (en) 1995-03-02
EP0714406B1 (de) 2004-04-21
DK1486511T3 (da) 2007-05-29

Similar Documents

Publication Publication Date Title
DE69433724D1 (de) Mit rekombinantem insulin-ähnlichen wachstumsfaktor igf-i vergleichbare rückfaltung von polypeptiden
PL323858A1 (en) Compounds and peptides capable to bond to a receptor of erythropoetin
IS5087A (is) Stöðugar interferónlyfjablöndur á vökvaformi
AU2223401A (en) Branched polyalkylene glycols
AU7180787A (en) Fibroblast growth factor
EP0316965A3 (de) Enzym-Inhibitoren
EP0722461A4 (de) Expression eines fusionspolypeptides, das ohne leadersequenz aus dem cytoplasma transportiert wird
ES2180523T3 (es) Composicion que comprende insulina nph (insulina neutra protamina de hagedorn).
EP0723013A3 (de) Biosynthetische knochenbildende Proteine, und sie enthaltende knochenbildende Vorrichtungen
AU6286986A (en) Peptide analogues of mammalian insulin-like growth factor-1
AU569776B2 (en) Atrial natriuretic factors
CA2094027A1 (en) Osteogenic peptides
ES2104635T3 (es) Nuevo peptido porcino con una actividad fisiologica (cnp-53).
ES8501364A1 (es) Un metodo para la preparacion de nuevos polipeptidos.
EP0475394A3 (en) Rat c-type natriuretic peptide cdna and precursor protein
KR910016767A (ko) 신규한 펩티드
KR850001287A (ko) 폴리펩타이드의 제조방법
CA2236751A1 (en) Method for producing a correctly folded, biological active recombinant protein
WO1998000460B1 (en) High-flowability polyamide resin composition
KR850700041A (ko) 티-세포 증식인자
Akhmedov et al. Electrodeposition of Tin--Nickel Alloy From Acid Electrolyte in the Presence of Aminoacetic Acid

Legal Events

Date Code Title Description
8364 No opposition during term of opposition